Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference CHARLOTTESVILLE, Va., Jan. 11, 2021 — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows: Event: Date: The recorded presentation can be accessed by conference participants and the presentation deck can be ...